Viral infections are historically very difficult to treat. Although imperfect and time-consuming to develop, we do have some conventional vaccine and therapeutic approaches to stop viral spreading. Most importantly, all of this takes significant time while viruses continue to wreak havoc on our healthcare system. Furthermore, viral infections are accompanied by a weakened immune system which is often overlooked in antiviral drug strategies and requires additional drug development. In this review, for the first time, we touch on some promising alternative approaches to treat viral infections, specifically those focused on the use of platform nanomaterials with antiviral peptides. In doing so, this review presents a timely discussion of how we need to change our old way of treating viruses into one that can quickly meet the demands of COVID-19, as well as future pandemic-causing viruses, which will come. Graphical abstract B and D reproduced with permission from [ 1 ] © 2020 Wrapp et al. , licensed with CC BY 4.0.
【저자키워드】 COVID-19, Nanotechnology, Nanoparticles, antiviral peptides, nanomaterials, 【초록키워드】 viruses, viral infection, Vaccine, Antiviral, Infection, viral infections, antiviral drug, Viral, peptides, platform, Healthcare system, Abstract, therapeutic approaches, treat, permission, MOST, weakened immune system, develop, approach, virus, therapeutic approach, time-consuming, accompanied, 【제목키워드】 pathogen, Pandemics, treated,